PubRank

Philipp A Schnabel

Author PubWeight™ 64.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 2012 4.30
2 Skeletal scintigraphy indicates disease severity of cardiac involvement in patients with senile systemic amyloidosis. Int J Cardiol 2011 2.10
3 Intraoperative radiofrequency ablation of lung metastases and histologic evaluation. Ann Thorac Surg 2009 1.49
4 Influence of different implantation techniques on AV valve competence after orthotopic heart transplantation. Eur J Cardiothorac Surg 2005 1.43
5 Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas. Eur Respir J 2012 1.17
6 Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies. Histopathology 2012 1.16
7 ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases. Histopathology 2014 1.10
8 Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma. Eur Respir J 2012 1.10
9 Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors. Cancer Biol Ther 2007 1.07
10 Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach. Virchows Arch 2012 1.07
11 Non-invasive predictors of survival in cardiac amyloidosis. Eur J Heart Fail 2007 1.05
12 Are we missing the target? Cancer stem cells and drug resistance in non-small cell lung cancer. Cancer Genomics Proteomics 2012 1.05
13 Foxp3(+) regulatory T cells and natural killer cells distinctly infiltrate primary tumors and draining lymph nodes in pulmonary adenocarcinoma. J Thorac Oncol 2011 1.04
14 Frequent hypermethylation of RASSF1A tumour suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer. Eur J Cancer 2009 1.02
15 Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification. Virchows Arch 2012 1.01
16 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy. Eur Respir J 2011 1.00
17 Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients. Lung Cancer 2013 1.00
18 Amyloid in endomyocardial biopsies. Virchows Arch 2010 1.00
19 Cystic thymoma. Pathol Oncol Res 2005 1.00
20 Lung sequestration: a rare cause for pulmonary symptoms in adulthood. Respiration 2011 0.96
21 Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay. Blood 2010 0.95
22 Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) in association with an adenocarcinoma: a case report. J Med Case Rep 2008 0.95
23 Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3. J Thorac Oncol 2011 0.94
24 Immunohistochemical and cytogenetic characterization of acantholytic squamous cell carcinoma of the breast. Virchows Arch 2005 0.94
25 KRAS-mutation positive, metastatic tonsil carcinoma with cancer stem-like cell features and long-term response to gefitinib: a case report and review of the literature. J Clin Oncol 2011 0.94
26 Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patients. Lung Cancer 2008 0.92
27 The cancer stem cell antigens CD133, BCRP1/ABCG2 and CD117/c-KIT are not associated with prognosis in resected early-stage non-small cell lung cancer. Anticancer Res 2011 0.91
28 EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype. Eur Respir J 2013 0.91
29 The efficacy of bipolar and multipolar radiofrequency ablation of lung neoplasms - results of an ablate and resect study. Eur J Cardiothorac Surg 2010 0.90
30 Thymolipoma. A report of nine cases, with emphasis on its association with myasthenia gravis. Surg Today 2010 0.90
31 Establishment and comparative characterization of novel squamous cell non-small cell lung cancer cell lines and their corresponding tumor tissue. Lung Cancer 2012 0.89
32 Pirfenidone in idiopathic pulmonary fibrosis: real-life experience from a German tertiary referral center for interstitial lung diseases. Respiration 2014 0.89
33 Endobronchial ultrasound-guided cryobiopsies in peripheral pulmonary lesions: a feasibility study. Eur Respir J 2013 0.87
34 Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas. Cancer Lett 2006 0.87
35 Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis. Eur J Cardiothorac Surg 2007 0.86
36 A pragmatic approach to the diagnosis of nodal micrometastases in early stage non-small cell lung cancer. J Thorac Oncol 2010 0.85
37 Impact of pre-operative diabetes mellitus upon early and late survival after heart transplantation: a possible era effect. J Heart Lung Transplant 2005 0.85
38 Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma. Int J Cancer 2008 0.85
39 Mesenchymal stem cells in non-small cell lung cancer--different from others? Insights from comparative molecular and functional analyses. Lung Cancer 2013 0.85
40 Invasive Aspergillus fumigatus infection after Plasmodium falciparum malaria in an immuno-competent host: case report and review of literature. Malar J 2009 0.83
41 Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC. Diagn Pathol 2014 0.82
42 Early detection of lung cancer by molecular markers in endobronchial epithelial-lining fluid. J Thorac Oncol 2012 0.82
43 Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis. Eur J Heart Fail 2009 0.82
44 Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer. Anticancer Res 2013 0.82
45 Chromosomal instability is more frequent in metastasized than in non-metastasized pulmonary carcinoids but is not a reliable predictor of metastatic potential. Exp Mol Med 2009 0.82
46 Analytically false or true positive elevations of high sensitivity cardiac troponin: a systematic approach. Heart 2013 0.81
47 A histochemical approach to the diagnosis of visceral pleural infiltration by non-small cell lung cancer. Pathol Oncol Res 2010 0.81
48 Treatment and outcome of lung cancer in idiopathic interstitial pneumonias. Sarcoidosis Vasc Diffuse Lung Dis 2015 0.81
49 COX-2 upregulation in thymomas and thymic carcinomas. Int J Cancer 2006 0.81
50 Characteristics and outcome of patients with second primary lung cancer. Eur Respir J 2012 0.81
51 Risk stratification in cardiac amyloidosis: novel approaches. Transplantation 2005 0.80
52 Inhibition of apoptosis by the intrinsic but not the extrinsic apoptotic pathway in myocardial ischemia-reperfusion. Cardiovasc Pathol 2013 0.80
53 Green tea halts progression of cardiac transthyretin amyloidosis: an observational report. Clin Res Cardiol 2012 0.80
54 Stage-specific embryonic antigen-4 is expressed in basaloid lung cancer and associated with poor prognosis. Eur Respir J 2012 0.80
55 Assessment of thymidylate synthase expression in biopsy specimens and corresponding resection specimens of non-small-cell lung cancer. Histopathology 2012 0.80
56 Morphometric changes of the right ventricle in the first two weeks after clinical heart transplantation: analysis of myocardial biopsies from patients with complicated versus uncomplicated course. Eur J Cardiothorac Surg 2006 0.79
57 The gefitinib long-term responder (LTR)--a cancer stem-like cell story? Insights from molecular analyses of German long-term responders treated in the IRESSA expanded access program (EAP). Lung Cancer 2012 0.79
58 Gene expression analysis of endobronchial epithelial lining fluid in the evaluation of indeterminate pulmonary nodules. J Thorac Cardiovasc Surg 2009 0.78
59 Biomarkers after heart transplantation: nongenomic. Heart Fail Clin 2007 0.78
60 Expression of platelet-derived growth factor and fibroblast growth factor in cryopreserved endomyocardial biopsies early and late after heart transplant. Ann Thorac Surg 2006 0.78
61 Allograft rejection of ISHLT grade >/=3A occurring late after heart transplantation--a distinct entity? J Heart Lung Transplant 2003 0.78
62 Loss of aquaporin-4 expression and putative function in non-small cell lung cancer. BMC Cancer 2011 0.78
63 Misalignment of pulmonary vessels with alveolar capillary dysplasia: association with atrioventricular septal defect and quadricuspid pulmonary valve. Virchows Arch 2005 0.78
64 The role of platelet derived growth factor in endomyocardial biopsies shortly after heart transplantation in relation to postoperative course. Eur J Cardiothorac Surg 2004 0.77
65 High prevalence of amyloid in 150 surgically removed heart valves--a comparison of histological and clinical data reveals a correlation to atheroinflammatory conditions. Cardiovasc Pathol 2009 0.77
66 Diagnostic efficiency of rejection monitoring after heart transplantation with cardiac troponin T is improved in specific patient subgroups. Clin Transplant 2003 0.77
67 The "Wagshurst study": p.Val40Ile transthyretin gene variant causes late-onset cardiomyopathy. Amyloid 2014 0.76
68 Determinants of B-type natriuretic peptide plasma levels in the chronic phase after heart transplantation. Transpl Int 2005 0.76
69 Chromosomal imbalances in sporadic neuroendocrine tumours of the thymus. Cancer Lett 2004 0.76
70 Preparation of cell blocks for lung cancer diagnosis and prediction: protocol and experience of a high-volume center. Respiration 2014 0.75
71 Trauma induced by nontraumatic coronary devices and its impact on vascular reactivity and morphology. Am J Physiol Heart Circ Physiol 2002 0.75
72 Inducible NO synthase expression in endomyocardial biopsies after heart transplantation in relation to the postoperative course. Eur J Cardiothorac Surg 2007 0.75
73 [Management of tumors with neuroendocrine differentiation]. Onkologie 2013 0.75
74 Extended resection of a plasmocytoma of bone and an amyloidoma of the chest wall. Ann Thorac Surg 2013 0.75
75 Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis. Amyloid 2014 0.75
76 A new tool for experimental tumour research. Oncol Rep 2006 0.75
77 Pulmonary vascular changes in piglets with increased pulmonary blood flow and pressure. Virchows Arch 2007 0.75